Sarcoma  >>  Neulasta (pegfilgrastim)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neulasta (pegfilgrastim) / Roche
NCT00612989: Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

Completed
1
42
US
Temodar and O6-Benzylguanine, Temodar, Temozolomide, O6-BG, O6-Benzylguanine, NSC637037, Neulasta, Pegfilgrastim
Duke University, Schering-Plough, Keryx / AOI Pharmaceuticals, Inc.
Glioblastoma, Gliosarcoma
08/07
07/08
NCT05043649: Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

Terminated
1
14
US
Camsirubicin
Monopar Therapeutics
Advanced Soft-tissue Sarcoma
10/23
05/24

Download Options